Marshall Wace’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.1M | Buy |
+75,977
| New | +$37.8M | 0.04% | 397 |
|
|
2025
Q3 | – | Sell |
-276,480
| Closed | -$79.4M | – | 3436 |
|
|
2025
Q2 | $79.4M | Buy |
276,480
+63,484
| +30% | +$19M | 0.09% | 212 |
|
|
2025
Q1 | $65.7M | Buy |
+212,996
| New | +$73M | 0.08% | 212 |
|
|
2024
Q4 | – | Sell |
-12,708
| Closed | -$4.55M | – | 3025 |
|
|
2024
Q3 | $4.55M | Sell |
12,708
-7,397
| -37% | -$2.5M | 0.01% | 1029 |
|
|
2024
Q2 | $6.4M | Sell |
20,105
-105,538
| -84% | -$27.9M | 0.01% | 902 |
|
|
2024
Q1 | $28.9M | Buy |
125,643
+115,788
| +1,175% | +$26.1M | 0.04% | 389 |
|
|
2023
Q4 | $2.17M | Buy |
9,855
+7,407
| +303% | +$1.71M | ﹤0.01% | 1187 |
|
|
2023
Q3 | $553K | Buy |
+2,448
| New | +$564K | ﹤0.01% | 1693 |
|
|
2023
Q1 | – | Sell |
-4,613
| Closed | -$1.28M | – | 3127 |
|
|
2022
Q4 | $1.28M | Buy |
+4,613
| New | +$1.16M | ﹤0.01% | 1970 |
|
|
2022
Q3 | – | Sell |
-2,449
| Closed | -$577K | – | 3817 |
|
|
2022
Q2 | $577K | Sell |
2,449
-27,151
| -92% | -$5.52M | ﹤0.01% | 2729 |
|
|
2022
Q1 | $5.31M | Buy |
+29,600
| New | +$5.64M | 0.01% | 1314 |
|
|
2021
Q4 | – | Sell |
-21,422
| Closed | -$3.95M | – | 4301 |
|
|
2021
Q3 | $3.95M | Buy |
+21,422
| New | +$4.22M | 0.02% | 1085 |
|
|
2021
Q2 | – | Sell |
-1,978
| Closed | -$331K | – | 3118 |
|
|
2021
Q1 | $331K | Sell |
1,978
-3,804
| -66% | -$634K | ﹤0.01% | 2097 |
|
|
2020
Q4 | $878K | Sell |
5,782
-6,194
| -52% | -$813K | ﹤0.01% | 1261 |
|
|
2020
Q3 | $1.21M | Sell |
11,976
-13,661
| -53% | -$1.5M | 0.01% | 956 |
|
|
2020
Q2 | $3.1M | Buy |
+25,637
| New | +$2.88M | 0.02% | 624 |
|
|
2020
Q1 | – | Sell |
-5,566
| Closed | -$490K | – | 2078 |
|
|
2019
Q4 | $490K | Buy |
+5,566
| New | +$490K | ﹤0.01% | 1182 |
|
|
2019
Q1 | – | Sell |
-17,819
| Closed | -$1.94M | – | 2073 |
|
|
2018
Q4 | $1.94M | Buy |
+17,819
| New | +$2.07M | 0.02% | 730 |
|
|
2018
Q3 | – | Sell |
-3,327
| Closed | -$376K | – | 1290 |
|
|
2018
Q2 | $376K | Buy |
+3,327
| New | +$366K | 0.01% | 606 |
|
|
2016
Q2 | – | Sell |
-67,886
| Closed | -$7.57M | – | 1180 |
|
|
2016
Q1 | $7.57M | Buy |
67,886
+65,899
| +3,317% | +$8.34M | 0.07% | 257 |
|
|
2015
Q4 | $311K | Sell |
1,987
-123,530
| -98% | -$18M | ﹤0.01% | 872 |
|
|
2015
Q3 | $16.5M | Buy |
125,517
+55,797
| +80% | +$8.95M | 0.2% | 127 |
|
|
2015
Q2 | $12.1M | Sell |
69,720
-2,864
| -4% | -$515K | 0.16% | 151 |
|
|
2015
Q1 | $12.5M | Sell |
72,584
-199,381
| -73% | -$30.4M | 0.16% | 162 |
|
|
2014
Q4 | $35.2M | Buy |
271,965
+202,820
| +293% | +$26.1M | 0.46% | 51 |
|
|
2014
Q3 | $8.9M | Buy |
69,145
+22,569
| +48% | +$2.33M | 0.13% | 201 |
|
|
2014
Q2 | $4.12M | Buy |
+46,576
| New | +$4.48M | 0.06% | 290 |
|
Other funds holding UTHR
ACA
VPM
VCM
Marshall Wace's UTHR Position: Q1 2026 in Review
Marshall Wace opened a new position in United Therapeutics (UTHR) in Q1 2026: 75,977 shares worth $45.1M. The stake represents 0.04% of the portfolio and ranks #397 among its holdings. This is a return to the name: Marshall Wace previously reported a position in UTHR as recently as Q2 2025.
Marshall Wace first reported a position in UTHR in Q2 2014 and has held it in 27 quarters since. The position peaked at $79.4M in Q2 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Marshall Wace held 75,977 shares of United Therapeutics worth $45.1M as of Q1 2026.
- United Therapeutics was a new Marshall Wace position in Q1 2026.
- United Therapeutics made up 0.04% of Marshall Wace's portfolio in Q1 2026, its #397 holding.
- Marshall Wace first reported a position in United Therapeutics in Q2 2014 and has held it in 27 quarters since.
- Marshall Wace's United Therapeutics position peaked at $79.4M in Q2 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.